Jon S. Saxe, Director at VistaGen Therapeutics, Inc. (VTGN), bought 30,000 shares at $0.69 ($21K) on 2020-08-21, disclosed to the SEC on 2020-08-24.
Open-market purchase of $21k VTGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |
| DRRX | BUY | 2019-03-15 | $5K | — | Filing → |